|
Respiratory distress syndrome (RDS), or hyaline membrane disease, occurs in premature babies who are born less than 35 weeks old. Their lungs have not yet developed surfactant, a substance that prevents the collapse of lungs. The rates of mortality in untreated babies are very high. Fortunately, recombinant or animal-based surfactant can be introduced into the baby's lungs to promote survival.
|